Menu
Currency
GWAS Study

Cancer risk susceptibility loci in a Swedish population.

Liu W, Jiao X, Thutkawkorapin J et al.

29299148 PubMed ID
GWAS Study Type
19136 Participants
93 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LW
Liu W
JX
Jiao X
TJ
Thutkawkorapin J
MH
Mahdessian H
LA
Lindblom A
Chapter II

Abstract

Summary of the research findings

A germline mutation in cancer predisposing genes is known to increase the risk of more than one tumor type. In order to find loci associated with many types of cancer, a genome-wide association study (GWAS) was conducted, and 3,555 Swedish cancer cases and 15,581 controls were analyzed for 226,883 SNPs. The study used haplotype analysis instead of single SNP analysis in order to find putative founder effects. Haplotype association studies identified seven risk loci associated with cancer risk, on chromosomes 1, 7, 11, 14, 16, 17 and 21. Four of the haplotypes, on chromosomes 7, 14, 16 and 17, were confirmed in Swedish familial cancer cases. It was possible to perform exome sequencing in one patient for each of those four loci. No clear disease-causing exonic mutation was found in any of the four loci. Some of the candidate loci hold several cancer genes, suggesting that the risk associated with one locus could involve more than one gene associated with cancer risk. In summary, this study identified seven novel candidate loci associated with cancer risk. It was also suggested that cancer risk at one locus could depend on multiple contributing risk mutations/genes.

3,555 Swedish ancestry cases, 15,581 Swedish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

19136
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Sweden
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.